on OXURION (EBR:OXUR)
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV, based in Leuven, Belgium, announced on June 18, 2026, that it has received a transparency notification from Atlas Special Opportunities II, LLC. This notification reveals that as of June 16, 2026, Atlas held 10,958,882 shares of Oxurion, which corresponds to just under 10% of the outstanding shares, following the sale of voting securities.
Atlas Special Opportunities II, LLC's shareholding represents a significant interest in Oxurion, a company known for its technology-oriented clinical research and software platform. This platform supports the pharmaceutical, biotechnology, and medical device sectors through the combination of clinical and software expertise.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news